Drug Shortage Report for JAMP-MOXIFLOXACIN
Report ID | 207295 |
Drug Identification Number | 02472120 |
Brand name | JAMP-MOXIFLOXACIN |
Common or Proper name | Moxifloxacin Ophthalmic Solution USP |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | MOXIFLOXACIN |
Strength(s) | 0.5% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 3 mL |
ATC code | S01AE |
ATC description | ANTIINFECTIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-10-16 |
Estimated end date | 2024-10-15 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-03-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-03-19 | French | Compare |
v5 | 2024-03-19 | English | Compare |
v4 | 2023-11-29 | French | Compare |
v3 | 2023-11-29 | English | Compare |
v2 | 2023-10-18 | French | Compare |
v1 | 2023-10-18 | English | Compare |
Showing 1 to 6 of 6